Jill James
Sandra Jill James is an American biochemist and autism researcher who studies metabolic autism
biomarkers. She works at
Arkansas Children's Hospital Research Institute, where she is the director of the Metabolic Genomics Laboratory, as well as the
University of Arkansas for Medical Sciences's department of pediatrics, where she has worked since 2002. She is also a member of the
Autism Speaks Treatment Advisory Board, and is also a scientific advisor to the autism foundation
N of One. Her current research focuses on the role of
epigenetics in causing autism, as well as the effectiveness of supplements as a treatment for autism and the potential existence of abnormal metabolism in autistic children. This research is funded by a 5-year grant from the
National Institutes of Health entitled "Metabolic biomarkers of autism: predictive potential and genetic susceptibility", as well as by a grant from
Autism Speaks.
Provided by Wikipedia